spacer
home > white papers > Achieve full compliance with tamper-verification pharma solutions - UPM Raflatac
WHITE PAPERS
logo_UPM_Raflat.jpg

UPM Raflatac

phone +358 2041 6143
web http://www.upmraflatac.com
email Tesomankatu 31, P.O. Box 53 33101 Tampere

Achieve full compliance with tamper-verification pharma solutions

UPM Raflatac has developed a range of pharmaceutical labelling products to support compliance with the Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. Few solutions offer the same ease of adoption for meeting the February 2019 deadline.
Achieve full compliance with tamper-verification pharma solutions
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

New Report Uncovers the Extent of Data Integrity Challenges for UK Pharmaceutical Manufacturers

Big data, audit trails, system integration and access privileges are among the most pressing data integrity challenges for pharmaceutical manufacturers, according to a new industry report published by Yokogawa. With many manufacturers already facing historical data integrity challenges, including hybrid systems and ageing equipment, the advent of digital transformation is set to place further pressure on manufacturers looking to remain on the right side of auditors.
More info >>


White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement